Liver Meeting 2022

Fenofibrate appears to improve cholestasis in patients experiencing ischemic cholangiopathy after liver transplant, ...

MAY 27, 2023

Researchers have embarked on a study to explore the relationship between variants of unknown significance in genes ...

MAY 26, 2023

The ileal bile acid transporter inhibitors odevixibat and maralixibat resulted in improvements in liver disease in ...

MAY 25, 2023

Bepirovirsen appears most effective in reducing hepatitis B viral levels at a dose of 300 mg for 24 weeks, ...

MAY 19, 2023

Terlipressin can improve disease parameters among patients with hepatorenal syndrome–acute kidney injury, a ...

MAY 18, 2023

In this second installment of “Expert Picks” from The Liver Meeting 2022, Ashwani K. Singal, MD, MS, ...

APRIL 19, 2023

New data are supporting the use of novel agents in the treatment of NASH, according to late-breaking abstracts ...

MARCH 28, 2023

Some patients presenting with any alcohol use disorder may be at higher risk for developing advanced liver disease ...

FEBRUARY 28, 2023

In this installment, Ashwani K. Singal, MD, MS, discusses five of this favorite abstracts presented at The Liver ...

FEBRUARY 17, 2023

Increased mortality rates for alcohol-associated liver disease and NAFLD among younger people and some ethnic ...

JANUARY 24, 2023

People with cirrhosis appeared to be significantly more protected with a third dose of a COVID vaccine instead of ...

JANUARY 23, 2023